VI
Viracta Therapeutics, Inc.
VIRX · OTC
$0.01 +0.00% (+$0.00)
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
8 /100
Unstable Beta 0.28x
EPS volatility 673.57%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na VIRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
26
Headquarters
Cardiff-by-the-Sea